Scarica l'app Stockscreener
3.89
0.52%
0.02
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
OBIO Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesRevenue Recognition Risk - newsline.com
Orchestra BioMed (OBIO) Edges Higher, Testing Key Resistance Zone on Modest VolumeLow Beta Factor - newsline.com
Orchestra BioMed (NASDAQ: OBIO) CFO has shares withheld to cover RSU tax obligations - Stock Titan
Orchestra BioMed (OBIO) insider uses 6,566 shares to cover RSU taxes - Stock Titan
Orchestra BioMed Grants Equity Awards to New Employees - MyChesCo
Number of shareholders of Orchestra BioMed Holdings, Inc. – NASDAQ:OBIO - TradingView
Orchestra BioMed Holdings (OBIO) Slips 2.26% as Shares Test Support Near $3.70Chart Pattern Alerts - newsline.com
Orchestra BioMed receives $20 million from Medtronic - Investing.com
OBIO: Upcoming BackBeat and Virtue trial milestones signal strong growth and partnership-driven value - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Insider Sell Alert: Darren Sherman Sells Shares of Orchestra Bio - GuruFocus
Insider Sell Alert: Darren Sherman Sells Shares of Orchestra BioMed Holdings Inc (OBIO) - GuruFocus
Orchestra BioMed (OBIO) director adds 5,000 shares in open-market buy - Stock Titan
Orchestra BioMed (OBIO) director Darren Sherman sells 15,000 shares under 10b5-1 plan - Stock Titan
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Affiliate sale notice: OBIO (NASDAQ: OBIO) proposes sale of 15,000 shares - Stock Titan
OBIO Q1 2026 Earnings: Narrower-Than-Expected Loss as Company Advances PipelineAnnual Report - newsline.com
Orchestra BioMed Holdings (OBIO) Slides 1.76% as Shares Test Key Support LevelsIron Condor Alert - thelegaladvocate.com
OBIO Q1 2026 Earnings: Narrower-Than-Expected Loss Fuels Optimism Amid Pre-Revenue StageHigh Growth Earnings - newsline.com
Orchestra BioMed (OBIO) CFO has 3,076 RSU shares withheld for taxes - Stock Titan
Orchestra BioMed (OBIO) insider reports RSU tax-withholding of 4,925 shares - Stock Titan
OBIO Q1 2026 Earnings: Loss Narrows More Than Expected, Stock Modestly DeclinesAnnual Earnings Summary - newsline.com
Orchestra BioMed (OBIO) Edges Higher: Navigating Key Support and Resistance LevelsPullback Trade - The Legal Advocate
OBIO Q1 2026 Earnings: EPS Beat Narrowed Losses, But No Revenue YetStrong Earnings Momentum - The Legal Advocate
OBIO Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline in Pre-Revenue Phase - Newser
Orchestra BioMed Holdings (OBIO) Slips Slightly as Stock Hovers Near SupportBreakaway Gap - newsline.com
OBIO Q1 2026 Earnings: Narrowed Loss as EPS Surpasses Estimates; Stock Posts Modest DeclineLong-Term Guidance - Newser
Orchestra BioMed Advances FDA Path for Hypertension Device - MyChesCo
Orchestra BioMed Targets 2027 Data for Hypertension Trial - MyChesCo
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock - Yahoo Finance
Orchestra BioMed director Jason buys $2,493 in stock - Investing.com UK
Orchestra BioMed director Jason buys $2,493 in stock By Investing.com - Investing.com Canada
Orchestra BioMed (OBIO) director adds 665 shares in open-market buy - Stock Titan
Orchestra BioMed Holdings (OBIO) price target increased by 11.30% to 12.68 - MSN
Orchestra BioMed CEO David Hochman buys $18,850 in company stock By Investing.com - Investing.com Nigeria
Orchestra BioMed director Aryeh Jason buys $34,986 in stock By Investing.com - Investing.com Nigeria
Orchestra BioMed director Aryeh Jason buys $34,986 in stock - Investing.com India
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire
Orchestra BioMed CEO David Hochman buys $18,850 in company stock - Investing.com
Director at Orchestra BioMed (OBIO) buys 8,971 shares in open market - Stock Titan
B. Riley Cuts Price Target on Orchestra BioMed Holdings to $10 From $12, Keeps Buy Rating - marketscreener.com
Orchestra BioMed director Fain buys $82,600 in shares By Investing.com - Investing.com South Africa
Orchestra BioMed director Fain buys $82,600 in shares - Investing.com UK
1.23%
1.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):